Pfizer CEO Albert Bourla Receives Routine Phantom Stock Allocation
PFIZER INC
Subscribe to track PFE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Pfizer Inc. ($PFE) | Form 4 Filing Insider: Albert Bourla (Chairman & CEO) Transaction: Acquired 20 Phantom Stock Units @ $30.52 ($610.40) Date: 2026-10-30 Holdings After: 783,828 Phantom Stock Units Significance: Low (Routine deferred compensation plan contribution)
Comprehensive Analysis
Insider Filing Analysis: Pfizer Inc. ($PFE)
Overview
On November 3, 2026, Pfizer Inc. reported an insider transaction by its Chairman and CEO, Albert Bourla. The transaction occurred on October 30, 2026, and involved an automatic acquisition of phantom stock units.
Transaction Details
- Security: Phantom Stock Units SSP
- Transaction Code: A (Award/Grant/Acquisition)
- Shares/Units: 20.00
- Price per Unit: $30.52
- Total Transaction Value: $610.40
- Post-Transaction Holdings: 783,828.00 phantom units
Plan Specifics & Context
According to the footnotes, these phantom stock units were acquired under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Each unit corresponds to one phantom share of common stock payable in cash upon separation from service.
Market Significance
- Trading Significance: Low
- Rationale: This is a routine, minimal deferred compensation contribution (~$610.40) consistent with automated executive savings plan allocations. It does not represent an open-market discretionary trade and carries no directional signal for investors.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.